Innoviva (INVA) Gross Margin (2011 - 2026)

Innoviva (INVA) reported Gross Margin of 77.39% for Q1 2026, down 533.0% on a YoY basis from 17.87% in Q1 2025, and up 10.43% quarter-over-quarter from 70.07% in Q3 2025.

Innoviva (INVA) Gross Margin (2011 - 2026) Analysis & Trends

Innoviva has reported Gross Margin for 9 years, with the latest figure at 77.39% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 533.0% year-over-year to 77.39%; the trailing twelve-month figure through Mar 2026 stood at 100.22% (down 412.0% YoY), and the FY2025 full-year result was 74.8%, down 778.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 77.39%, up from 70.07% in the prior quarter.
  • The five-year high for Gross Margin was 6220.29% in Q1 2024, with the low at 816.22% in Q2 2023.
  • Historically, Gross Margin has averaged 475.6% across 5 years, with a median of 82.91% in 2025.
  • Annual changes were most pronounced in 2024 — Gross Margin surged 632129 bps — and 2025, when it plunged 613757 bps.
  • Innoviva's Gross Margin stood at 100.0% in 2022, then changed by 0 bps to 100.0% in 2023, then decreased by 18 bps to 81.56% in 2024, then decreased by 14 bps to 70.07% in 2025, then rose by 10 bps to 77.39% in 2026.
  • The last three Gross Margin figures came in at 77.39% (Q1 2026), 70.07% (Q3 2025), and 82.91% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Innoviva 1.65 Bn 1.05 Bn 75.83 Mn 77.39%

Historic Data

Download Data
DateValue
Mar 31, 2026 77.39%
Sep 30, 2025 70.07%
Jun 30, 2025 82.91%
Mar 31, 2025 82.72%
Sep 30, 2024 81.56%
Jun 30, 2024 85.07%
Mar 31, 2024 6,220.29%
Sep 30, 2023 100.00%
Jun 30, 2023 -816.22%
Mar 31, 2023 -101.01%
Sep 30, 2022 100.00%
Jun 30, 2022 100.00%
Mar 31, 2022 100.00%
Sep 30, 2021 100.00%
Mar 31, 2014 75.90%
Mar 31, 2013 100.00%
Dec 31, 2011 100.00%
Sep 30, 2011 100.00%
Jun 30, 2011 81.58%